BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15886814)

  • 1. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
    Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
    Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
    Moatti D; Faure S; Fumeron F; Amara Mel-W; Seknadji P; McDermott DH; Debré P; Aumont MC; Murphy PM; de Prost D; Combadière C
    Blood; 2001 Apr; 97(7):1925-8. PubMed ID: 11264153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
    Nassar BA; Nanji AA; Ransom TP; Rockwood K; Kirkland SA; Macpherson K; Connelly PW; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Title LM
    Scand J Clin Lab Invest; 2008; 68(4):286-91. PubMed ID: 18609106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor.
    Ghilardi G; Biondi ML; Turri O; Guagnellini E; Scorza R
    Stroke; 2004 Jun; 35(6):1276-9. PubMed ID: 15118174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
    Matzhold EM; Trummer O; Grünbacher G; Zulus B; Boehm BO; März W; Renner W
    Cytokine; 2009 Sep; 47(3):224-7. PubMed ID: 19628406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distribution of HIV-1 coreceptor CX3CR1 allelic polymorphisms in general population, HIV-1 high-risk group and HIV-1 carriers of Chinese indigenous Han and Uygur people].
    Liu MX; Wang FS; Hong WG; Wang CQ; Wang B; Jin L; Hou J; Lei ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):595-8. PubMed ID: 12975017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
    Apostolakis S; Baritaki S; Kochiadakis GE; Igoumenidis NE; Panutsopulos D; Spandidos DA
    Thromb Res; 2007; 119(1):63-71. PubMed ID: 16480760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.
    Singh N; Rai H; Sinha N; Kumar S; Pandey CM; Agrawal S
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):756-60. PubMed ID: 22731642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
    Niessner A; Marculescu R; Kvakan H; Haschemi A; Endler G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
    Thromb Haemost; 2005 Dec; 94(6):1251-6. PubMed ID: 16411402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
    McDermott DH; Fong AM; Yang Q; Sechler JM; Cupples LA; Merrell MN; Wilson PW; D'Agostino RB; O'Donnell CJ; Patel DD; Murphy PM
    J Clin Invest; 2003 Apr; 111(8):1241-50. PubMed ID: 12697743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
    Sirois-Gagnon D; Chamberland A; Perron S; Brisson D; Gaudet D; Laprise C
    Obesity (Silver Spring); 2011 Jan; 19(1):222-7. PubMed ID: 20523302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.
    Yadav AK; Kumar V; Jha V
    Indian J Nephrol; 2016; 26(4):275-9. PubMed ID: 27512300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis.
    Apostolakis S; Amanatidou V; Papadakis EG; Spandidos DA
    Atherosclerosis; 2009 Nov; 207(1):8-15. PubMed ID: 19439304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.
    Faure S; Meyer L; Costagliola D; Vaneensberghe C; Genin E; Autran B; Delfraissy JF; McDermott DH; Murphy PM; Debré P; Théodorou I; Combadière C
    Science; 2000 Mar; 287(5461):2274-7. PubMed ID: 10731151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association of Fractalkine Receptor (T280M) Polymorphism in the Pathogenesis of Acute Coronary Syndrome in the Egyptian Population.
    Hassan DS; Hashad IM; Abdel Rahman MF; Abdel-Maksoud SM
    Curr Pharm Biotechnol; 2018; 19(11):869-876. PubMed ID: 30381070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1
    Church KA; Rodriguez D; Mendiola AS; Vanegas D; Gutierrez IL; Tamayo I; Amadu A; Velazquez P; Cardona SM; Gyoneva S; Cotleur AC; Ransohoff RM; Kaur T; Cardona AE
    Front Immunol; 2023; 14():1130735. PubMed ID: 37033925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.
    McDermott DH; Halcox JP; Schenke WH; Waclawiw MA; Merrell MN; Epstein N; Quyyumi AA; Murphy PM
    Circ Res; 2001 Aug; 89(5):401-7. PubMed ID: 11532900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease.
    Lavergne E; Labreuche J; Daoudi M; Debré P; Cambien F; Deterre P; Amarenco P; Combadière C;
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):847-53. PubMed ID: 15681302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.